The influence of an anti-steroidogenic drug (aminoglutethimide phosphate) on pregnancy maintenance.
D000028:Abortion, Induced; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001711:Biotransformation; D002784:Cholesterol / Q000378:metabolism; D003338:Corpus Luteum / Q000187:drug effects / Q000378:metabolism; D003864:Depression, Chemical; D005260:Female; D008297:Male; D008722:Methods; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D011284:Pregnenolone / Q000097:blood / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism* / Q000494:pharmacology; D011485:Protein Binding; D011728:Pyridones / Q000494:pharmacology*; D051381:Rats; D014316:Tritium
D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide; D014316:Tritium; D011374:Progesterone; D011284:Pregnenolone; D002784:Cholesterol